Puja P. Khanna

Suggest Changes

Writes About:

Learn More
OBJECTIVES Determine the efficacy and safety of daily lesinurad (200 or 400 mg orally) added to allopurinol in patients with serum uric acid (sUA) above target in a 12-month, randomised, phase III(More)